Nystatin

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Nystatin
Generic name: NYSTATIN
Manufacturer: RedPharm Drug, Inc
Product type: HUMAN PRESCRIPTION DRUG
SPL set ID: f4c298d5-b012-7b56-e053-2a95a90a3d55
SPL ID: 4922a3ab-05b8-2ff2-e063-6294a90a9fd4
Version: 4
Effective date: 2026-01-24
Source export date: 2026-09-28
Source partition: 3
Source file: https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/fd09911bd1bc81f7f2faeb048e63855fe224e494376ae919a0035190e315c050/drug-label-0003-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:18:58

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 14 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application applno	ANDA	212557	derived:openfda.application_number
application number		ANDA212557	openfda.application_number
brand name		Nystatin	openfda.brand_name
generic name		NYSTATIN	openfda.generic_name
manufacturer name		RedPharm Drug, Inc	openfda.manufacturer_name
ndc	package	67296-1519-1	openfda.package_ndc
ndc	package	67296-1519-3	openfda.package_ndc
ndc	product	67296-1519	openfda.product_ndc
ndc11	package	67296151901	derived:openfda.package_ndc
ndc11	package	67296151903	derived:openfda.package_ndc
rxcui		543546	openfda.rxcui
spl id		4922a3ab-05b8-2ff2-e063-6294a90a9fd4	id
spl set id		f4c298d5-b012-7b56-e053-2a95a90a3d55	set_id
unii		BDF1O1C72E	openfda.unii

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

ADVERSE REACTIONS The frequency of adverse events reported in patients using nystatin cream is less than 0.1%. The more common events that were reported include allergic reactions, burning, itching, rash, eczema, and pain on application. (See PRECAUTIONS: General. )

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.